172 related articles for article (PubMed ID: 20146162)
1. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis].
Morawietz H
Dtsch Med Wochenschr; 2010 Feb; 135(7):308-12. PubMed ID: 20146162
[TBL] [Abstract][Full Text] [Related]
2. LOX-1 in Cardiovascular Disease: A Comprehensive Molecular and Clinical Review.
Sánchez-León ME; Loaeza-Reyes KJ; Matias-Cervantes CA; Mayoral-Andrade G; Pérez-Campos EL; Pérez-Campos-Mayoral L; Hernández-Huerta MT; Zenteno E; Pérez-Cervera Y; Pina-Canseco S
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791315
[TBL] [Abstract][Full Text] [Related]
3. Role of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Inflammation and Pathogen-Associated Interactions.
Truthe S; Klassert TE; Schmelz S; Jonigk D; Blankenfeldt W; Slevogt H
J Innate Immun; 2024; 16(1):105-132. PubMed ID: 38232720
[TBL] [Abstract][Full Text] [Related]
4. Radical Oxygen Species, Oxidized Low-Density Lipoproteins, and Lectin-like Oxidized Low-Density Lipoprotein Receptor 1: A Vicious Circle in Atherosclerotic Process.
Munno M; Mallia A; Greco A; Modafferi G; Banfi C; Eligini S
Antioxidants (Basel); 2024 May; 13(5):. PubMed ID: 38790688
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic Regulation of the Lectin-Like Oxidized Lipoprotein Receptor LOX-1.
Mentrup T; Cabrera-Cabrera F; Schröder B
Front Cardiovasc Med; 2020; 7():594441. PubMed ID: 33553253
[TBL] [Abstract][Full Text] [Related]
6. Differential Effects of LOX-1 Inhibition on Aortic Structure and Posterior Cerebral Artery Structure and Function in an Experimental Model of Preeclampsia.
Anderson JL; McGreer JA; Tremble SM; Tainter-Gilbert AV; Cipolla MJ
Reprod Sci; 2024 Jun; ():. PubMed ID: 38858329
[TBL] [Abstract][Full Text] [Related]
7. Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1.
Schreurs MP; Hubel CA; Bernstein IM; Jeyabalan A; Cipolla MJ
FASEB J; 2013 Mar; 27(3):1254-63. PubMed ID: 23230281
[TBL] [Abstract][Full Text] [Related]
8. Haplo-insufficiency of Profilin1 in vascular endothelial cells is beneficial but not sufficient to confer protection against experimentally induced atherosclerosis.
Allen-Gondringer A; Gau D; Dutta P; Roy P
Cytoskeleton (Hoboken); 2024 Apr; ():. PubMed ID: 38623956
[TBL] [Abstract][Full Text] [Related]
9. Haplo-insufficiency of Profilin1 in vascular endothelial cells is beneficial but not sufficient to confer protection against experimentally induced atherosclerosis.
Allen-Gondringer A; Gau D; Dutta P; Roy P
bioRxiv; 2024 Mar; ():. PubMed ID: 38106044
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced NOS1 as a therapeutic target in hypercholesterolemia-related colorectal cancer.
Qiu W; Zhao L; Liu H; Xu P; Qian C
Cancer Metab; 2024 May; 12(1):14. PubMed ID: 38755702
[TBL] [Abstract][Full Text] [Related]
11. Animal Models in Cardiovascular Research: Hypertension and Atherosclerosis.
Leong XF; Ng CY; Jaarin K
Biomed Res Int; 2015; 2015():528757. PubMed ID: 26064920
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of statin-mediated LOX-1 inhibition.
Biocca S; Iacovelli F; Matarazzo S; Vindigni G; Oteri F; Desideri A; Falconi M
Cell Cycle; 2015; 14(10):1583-95. PubMed ID: 25950192
[TBL] [Abstract][Full Text] [Related]
13. Oxidized LDL attenuates protective autophagy and induces apoptotic cell death of endothelial cells: Role of oxidative stress and LOX-1 receptor expression.
Mollace V; Gliozzi M; Musolino V; Carresi C; Muscoli S; Mollace R; Tavernese A; Gratteri S; Palma E; Morabito C; Vitale C; Muscoli C; Fini M; Romeo F
Int J Cardiol; 2015 Apr; 184():152-158. PubMed ID: 25703423
[TBL] [Abstract][Full Text] [Related]
14. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo.
Akhmedov A; Rozenberg I; Paneni F; Camici GG; Shi Y; Doerries C; Sledzinska A; Mocharla P; Breitenstein A; Lohmann C; Stein S; von Lukowicz T; Kurrer MO; Borén J; Becher B; Tanner FC; Landmesser U; Matter CM; Lüscher TF
Eur Heart J; 2014 Oct; 35(40):2839-48. PubMed ID: 24419805
[TBL] [Abstract][Full Text] [Related]
15. LOX-1, OxLDL, and atherosclerosis.
Pirillo A; Norata GD; Catapano AL
Mediators Inflamm; 2013; 2013():152786. PubMed ID: 23935243
[TBL] [Abstract][Full Text] [Related]
16. An endothelial receptor for oxidized low-density lipoprotein.
Sawamura T; Kume N; Aoyama T; Moriwaki H; Hoshikawa H; Aiba Y; Tanaka T; Miwa S; Katsura Y; Kita T; Masaki T
Nature; 1997 Mar; 386(6620):73-7. PubMed ID: 9052782
[TBL] [Abstract][Full Text] [Related]
17. Novel function of fluvastatin in attenuating oxidized low-density lipoprotein-induced endothelial cell ferroptosis in a glutathione peroxidase4- and cystine-glutamate antiporter-dependent manner.
Li Q; Liu C; Deng L; Xie E; Yadav N; Tie Y; Cheng Z; Deng J
Exp Ther Med; 2021 Nov; 22(5):1275. PubMed ID: 34594412
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1β Regulates Lipid Homeostasis in Human Glomerular Mesangial Cells.
Liu H; Deng Y; Wu L; Li Y; Lin N; Li W; Dong X; Ma L
J Nutr Health Aging; 2020; 24(3):246-250. PubMed ID: 32115603
[TBL] [Abstract][Full Text] [Related]
19. Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention.
Liu J; Liu Y; Jia K; Huo Z; Huo Q; Liu Z; Li Y; Han X; Wang R
Medicine (Baltimore); 2018 Apr; 97(17):e0366. PubMed ID: 29702981
[TBL] [Abstract][Full Text] [Related]
20. Expression of LOX-1 in human mesangial cells is increased by Ox-LDL and IL-1β treatment.
Deng Y; Lin N; Wu L; Jia Q; Liu H
Exp Ther Med; 2017 Oct; 14(4):3632-3636. PubMed ID: 29042958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
